Literature DB >> 8240075

Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

J Stange1, W Ramlow, S Mitzner, R Schmidt, H Klinkmann.   

Abstract

The removal of protein-bound substances of pathogenetic relevance from blood is of therapeutic interest for drug intoxications, renal and liver failure, and metabolic disorders. Current methods using adsorbents are effective but often not specific enough. This work presents an alternative method that enables the dialyzability of albumin-bound toxins from plasma by the use of a high-flux dialyzer (F 60 Fresenius) and an albumin solution circulating on the dialysate side to increase selectively the affinity for albumin-bound toxins. This method resulted in effective removal of unconjugated bilirubin, drugs with a high protein-binding ratio (sulfobromophthalein, theophylline), and a protein-bound toxin (phenol). The additional removal of PBS could extend the applicability of dialysis, for example, to drug intoxications and liver failure or could improve the elimination of protein-bound uremic toxins in chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240075     DOI: 10.1111/j.1525-1594.1993.tb00635.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  25 in total

1.  Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.

Authors:  Taru Kantola; Suvi Mäklin; Anna-Maria Koivusalo; Pirjo Räsänen; Anne Rissanen; Risto Roine; Harri Sintonen; Krister Höckerstedt; Helena Isoniemi
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Prospects for extracorporeal liver support.

Authors:  R Jalan; S Sen; R Williams
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Comparison of two different modes of molecular adsorbent recycling systems for liver dialysis.

Authors:  Euan Soo; Anja Sanders; Karlheinz Heckert; Tobias Vinke; Franz Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2016-07-09       Impact factor: 3.714

Review 4.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

Review 5.  Clinical use of albumin in hepatology.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Antonio Gasbarrini
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 6.  Extracorporeal liver support.

Authors:  Jan Stange
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

Review 7.  The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children.

Authors:  Betti Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

8.  Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs.

Authors:  Sambit Sen; Lars M Ytrebø; Christopher Rose; Ole-Martin Fuskevaag; Nathan A Davies; Geir I Nedredal; Roger Williams; Arthur Revhaug; Rajiv Jalan
Journal:  Intensive Care Med       Date:  2004-01-21       Impact factor: 17.440

9.  Adult-Derived Human Liver Stem/Progenitor Cells Infused 3 Days Postsurgery Improve Liver Regeneration in a Mouse Model of Extended Hepatectomy.

Authors:  Astrid Herrero; Julie Prigent; Catherine Lombard; Valérie Rosseels; Martine Daujat-Chavanieu; Karine Breckpot; Mustapha Najimi; Gisèle Deblandre; Etienne M Sokal
Journal:  Cell Transplant       Date:  2016-09-21       Impact factor: 4.064

Review 10.  Role of artificial liver support in hepatic encephalopathy.

Authors:  V Stadlbauer; G A K Wright; R Jalan
Journal:  Metab Brain Dis       Date:  2008-12-21       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.